| Style | Citing Format |
|---|---|
| MLA | Parvaneh N, et al.. "Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition." Journal of Human Immunity, vol. 2, no. 2, 2026, pp. -. |
| APA | Parvaneh N, Karami H, Shahbaznejad L, Rezaei Z, Rostami P, Shahrooei M, Ziaee V (2026). Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition. Journal of Human Immunity, 2(2), -. |
| Chicago | Parvaneh N, Karami H, Shahbaznejad L, Rezaei Z, Rostami P, Shahrooei M, Ziaee V. "Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition." Journal of Human Immunity 2, no. 2 (2026): -. |
| Harvard | Parvaneh N et al. (2026) 'Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition', Journal of Human Immunity, 2(2), pp. -. |
| Vancouver | Parvaneh N, Karami H, Shahbaznejad L, Rezaei Z, Rostami P, Shahrooei M, et al.. Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition. Journal of Human Immunity. 2026;2(2):-. |
| BibTex | @article{ author = {Parvaneh N and Karami H and Shahbaznejad L and Rezaei Z and Rostami P and Shahrooei M and Ziaee V}, title = {Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition}, journal = {Journal of Human Immunity}, volume = {2}, number = {2}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Parvaneh N AU - Karami H AU - Shahbaznejad L AU - Rezaei Z AU - Rostami P AU - Shahrooei M AU - Ziaee V TI - Tlr7 F507s Gain-Of-Function Mutation Presenting With Early-Onset Sle and Hypertriglyceridemia: Response to Jak Inhibition JO - Journal of Human Immunity VL - 2 IS - 2 SP - EP - PY - 2026 ER - |